LIFECORE BIOMEDICAL, INC. Deferred Federal Income Tax Expense (Benefit)
LIFECORE BIOMEDICAL, INC. (LFCR) reported Deferred Federal Income Tax Expense (Benefit) of $160.00 thousand for the 7-month period ending 2025-12-31, per its 10-KT filed 2026-03-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-03-16
- LIFECORE BIOMEDICAL, INC. deferred federal income tax expense (benefit) for fiscal 2025 was -$124.00K, a 171.68% decline from fiscal 2024.
- LIFECORE BIOMEDICAL, INC. deferred federal income tax expense (benefit) for fiscal 2024 was $173.00K, a 26.07% decline from fiscal 2023.
- LIFECORE BIOMEDICAL, INC. deferred federal income tax expense (benefit) for fiscal 2023 was $234.00K.
- LIFECORE BIOMEDICAL, INC. deferred federal income tax expense (benefit) for fiscal 2022 was -$4.94M.
| Period end | Deferred Federal Income Tax Expense (Benefit) 7 month | Deferred Federal Income Tax Expense (Benefit) 12 month | Deferred Federal Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | $160.00K 10-KT · filed 2026-03-16 | ||
| 2025-05-25 | -$124.00K 10-KT · filed 2026-03-16 | ||
| 2024-05-26 | $173.00K 10-KT · filed 2026-03-16 | ||
| 2023-05-28 | $234.00K 10-K · filed 2024-08-26 | ||
| 2022-05-29 | -$4.94M 10-K · filed 2024-08-26 | -$5.56M 10-K · filed 2022-09-14 | |
| 2021-05-30 | -$5.98M 10-K · filed 2024-03-20 | -$7.43M 10-K · filed 2021-07-29 | |
| 2020-05-31 | -$983.00K 10-K/A · filed 2023-03-16 | -$5.21M 10-K · filed 2020-08-14 | |
| 2019-05-26 | $1.58M 10-K · filed 2021-07-29 | ||
| 2018-05-27 | -$7.12M 10-K · filed 2020-08-14 | ||
| 2017-05-28 | $2.27M 10-K · filed 2019-08-01 | $2.24M 10-K · filed 2017-08-11 | |
| 2016-05-29 | -$9.16M 10-K · filed 2018-08-09 | -$9.18M 10-K · filed 2016-08-01 | |
| 2015-05-31 | $3.79M 10-K/A · filed 2018-03-15 | ||
| 2014-05-25 | $5.06M 10-K · filed 2016-08-01 | ||
| 2013-05-26 | $6.22M 10-K · filed 2015-07-31 | ||
| 2012-05-27 | $2.64M 10-K · filed 2014-08-01 | ||
| 2011-05-29 | $3.14M 10-K · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |